✦ LIBER ✦

A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortium

✍ Scribed by Srikala S. Sridhar, Mary J. Mackenzie, Sebastien J. Hotte, Som D. Mukherjee, Ian F. Tannock, Nevin Murray, Christian Kollmannsberger, Masoom A. Haider, Eric X. Chen, Robert Halford, Lisa Wang, S. Percy Ivy, Malcolm J. Moore…show all 13hide

Book ID: 120966764
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 285 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-013-9931-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of the Src kinase inhib

A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium

✍ Helen J. Mackay, Heather J. Au, Elaine McWhirter, Thierry Alcindor, Andrea Jarvi 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 116 KB

A Phase II Study of GW786034 Using a Ran

A Phase II Study of GW786034 Using a Randomized Discontinuation Design in Patients with Locally Recurrent or Metastatic Clear-Cell Renal Cell Carcinoma

✍ Thomas E. Hutson; Ronald M. Bukowski 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 857 KB

A phase II trial of modified weekly irin

A phase II trial of modified weekly irinotecan and cisplatin for chemotherapy-naïve patients with metastatic or recurrent squamous cell carcinoma of the esophagus

✍ Dae Ho Lee; Heung Tae Kim; Ji-Youn Han; Sung Young Lee; Sung Jin Yoon; Hyae Youn 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 267 KB

A Phase II Trial of Panobinostat, a Hist

A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma

✍ Hainsworth, John D.; Infante, Jeffrey R.; Spigel, David R.; Arrowsmith, Edward R 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 194 KB

A Phase II Trial of Bryostatin-1 in Pati

A Phase II Trial of Bryostatin-1 in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

✍ David G. Pfister; John McCaffrey; Andrew J. Zahalsky; Gary K. Schwartz; Eric Lis 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 77 KB

Randomized Phase II Trial of First-Line

Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma

✍ Coplen, D.E. 📂 Article 📅 2009 🏛 Elsevier Science ⚖ 69 KB